SS-31 (Elamipretide) may be one of the most fascinating peptides ever developed.

Unlike most peptides that work by activating receptors on the surface of cells, SS-31 targets the mitochondria—the cellular power plants responsible for producing energy.

In this episode of Peptides Explained, we break down:

✅ What mitochondria actually do
✅ The role of cardiolipin in cellular energy production
✅ How SS-31 works biologically
✅ Why SS-31 received FDA Accelerated Approval in 2025
✅ What Barth Syndrome is
✅ The latest human clinical data
✅ How SS-31 compares with MOTS-c
✅ Whether repairing mitochondria before metabolic optimization makes biological sense

We'll separate proven science from speculation and discuss what remains investigational.

This podcast is for informational purposes only and is not medical advice.

Support the Show

Peptides Explained is an affiliate partner with OfflinePeptides.com. If you use my link, I may earn a commission at no additional cost to you.

https://offlinepeptides.com/ref/JohnGarrett/

For peptide education, provider resources, and information about compounded peptide options through licensed providers:

https://peptide-solutions.info

#PeptidesExplained #SS31 #Elamipretide #Forzinity #BarthSyndrome #Mitochondria #Longevity #MOTSc #Peptides